Infectious Diseases Consultation Servives in combination with Antibiotic Stewardship Activities in German Non-University Hospitals
- Conditions
- staphylococcus aureus bacteremia community-acquired pneumonia
- Registration Number
- DRKS00023710
- Lead Sponsor
- Abteilung Infektiologie, Klinik für Innere Medizin II, Department Innere Medizin, Universiätsklinikum Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 945
one of the two indicator diseases (S. aureus bacteremia [SAB], outpatient acquired pneumonia [CAP])
Existence of incomplete data regarding indicator diseases.
Regarding CAP: no new/admitted infiltrate, younger 18 years, neutropenia (<500 neutrophils/ul), steroid daily dose (>20mg prednisone equivalent), recent organ transplant, recent autologous/allogeneic stem cell transplant, HIV infection (viral load>20Cop/ml), symptom onset >48 hours after hospitalisation, hospitalisation within 30 days prior to presentation to physician, pneumonia diagnosis >48 hours after endotracheal intubation, COVID-19 infection, patient in psychiatric care.
Regarding SAB: younger 18 years, proven s.aureus bacteraemia, patient in psychiatric care, palliative therapy concept, deceased within 48 hours after hospitalisation.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Infectiological quality of care as well as antibiotic prescription quality and density of prescriptions were assessed as SAB-Score (5 items, 1 point each) and CAP-Score (4 items, 1 point each)
- Secondary Outcome Measures
Name Time Method Patient-related: hospital mortality, length of hospital stay, readmission within 4 weeks, C. difficile incidence, anti-infective costs, microbiological/virological diagnostic costs; hospital-related: Antibiotics prescription quality and density, total cost calculation